Article
Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.
Transfusion - 1 Sept 2017
Gehrie Eric A, Ness Paul M, Bloch Evan M, Kacker Seema, Tobian Aaron A R
Abstract excerpt
BACKGROUND: The pathogenesis of alloimmunization is not well understood, and initiatives that aim to reduce the incidence of alloimmunization are generally expensive and either ineffective or unproven. In this review, we summarize the current medical literature regarding alloimmunization in the sickle cell disease (SCD) population, with a special focus on the financial implications of different approaches to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.